Oliver Metzing
Muenster, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Markers and regulators of osteoblast and osteoclast activity in children with X-linked hypophosphatemia treated with burosumab.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: October 30, 2025
Anthropometric characteristics at birth and growth outcome in patients with X-linked hypophosphatemia treated with oral phosphate and active vitamin D.
Journal: Pediatric nephrology (Berlin, Germany)
Published: September 09, 2025
Growth dynamics of transversal body dimensions and proportions, with related clinical determinants in children with X-linked hypophosphatemia treated with phosphate supplements and active vitamin D.
Journal: Pediatric nephrology (Berlin, Germany)
Published: February 08, 2025
Office Blood Pressure and Obesity in Children with X-Linked Hypophosphatemia.
Journal: Calcified tissue international
Published: December 11, 2024
Preclinical Detection of Early Glomerular Injury in Children with Kidney Diseases-Independently of Usual Markers of Kidney Impairment and Inflammation.
Journal: International journal of molecular sciences
Published: July 19, 2024
Health-related quality of life of children with X-linked hypophosphatemia in Germany.
Journal: Pediatric nephrology (Berlin, Germany)
Published: March 08, 2024
Urinary Protein-Biomarkers Reliably Indicate Very Early Kidney Damage in Children With Alport Syndrome Independently of Albuminuria and Inflammation.
Journal: Kidney international reports
Published: July 25, 2023
Effects of Burosumab Treatment on Mineral Metabolism in Children and Adolescents With X-linked Hypophosphatemia.
Journal: The Journal of clinical endocrinology and metabolism
Published: November 25, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026